Clinical trial

Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects

NCT00857870

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE4

Study timeline

Study start (unknown)2009-03-01Date precision: month

Registry last updated2012-01-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

MetforminDRUG · verified · RxNorm: metformin

Insulin glargineDRUG · verified · RxNorm: insulin glargine

Sponsors & collaborators

GWT-TUD GmbHlead sponsor

Mapped research locations

DresdenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00857870 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.